These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11776320)

  • 21. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx.
    Mazzucato M; De Marco L; Pradella P; Masotti A; Pareti FI
    Thromb Haemost; 1996 Apr; 75(4):655-60. PubMed ID: 8743195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of transgenic mice expressing human platelet glycoprotein Ib alpha.
    Kitaguchi T; Murata M; Kuramochi T; Kobayashi K; Ito M; Ueyama Y; Nomura T; Hikichi K; Miyakawa Y; Handa M; Hiraoka Y; Aiso S; Ikeda Y
    Biochem Biophys Res Commun; 1996 Mar; 220(2):418-24. PubMed ID: 8645320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion.
    Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y
    Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the von Willebrand factor A1 domain to histone.
    Ward CM; Tetaz TJ; Andrews RK; Berndt MC
    Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
    Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom.
    Hamako J; Matsui T; Nishida S; Nomura S; Fujimura Y; Ito M; Ozeki Y; Titani K
    Thromb Haemost; 1998 Sep; 80(3):499-505. PubMed ID: 9759634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B; Houllier A; Meyer D; Girma JP
    Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
    Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
    Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom.
    Wang WJ; Huang TF
    Thromb Haemost; 2002 Apr; 87(4):641-50. PubMed ID: 12008947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom.
    Hamako J; Matsui T; Suzuki M; Ito M; Makita K; Fujimura Y; Ozeki Y; Titani K
    Biochem Biophys Res Commun; 1996 Sep; 226(1):273-9. PubMed ID: 8806626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine structural and functional consequences of deglycosylation of the platelet adhesion receptor GPIb-IX (CD 42b).
    Moshfegh K; Lengweiler S; Häner M; Aebi U; Steiner B; Beer JH
    Biochem Biophys Res Commun; 1998 Aug; 249(3):903-9. PubMed ID: 9731234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
    Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
    Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.
    Kawasaki T; Taniuchi Y; Hisamichi N; Fujimura Y; Suzuki M; Titani K; Sakai Y; Kaku S; Satoh N; Takenaka T
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):947-53. PubMed ID: 8948455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ; Huang TF
    Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.